Upload
kerotankerotan
View
212
Download
0
Embed Size (px)
DESCRIPTION
Rheumatology Objectives
Citation preview
Clinical Medicine III: Block I, MSK Objectives 7: Rheumatology Jimmy Bui
RHEUMATOLOGY
READING: Cecil Chapters 80 [pages 495-496], 264, 265, 266, 267, 273, 274, 275, 276, 277, 278, 279 & 282; EMC pages 45-51, 858-860, 354-357 & 419; | Porth Chapter 43, pages 1119-1131
Fast Facts Drugs Rheumatology: field that deals with dz involving joints, autoimmunity or both Inflammatory arthrides: RA, spondyloarthritis, infn, crystal-induced
o Aggravation c/ rest, alleviated c/ use, warmth, redness of jts + constitutional sx (e.g. wt loss, fever, fatigue
Non-inflammatory arthrides: OA, trauma, hemarthrosiso Aggravation c/ motion, alleviated c/ rest
Kills inflammatory cells – methotrexate, cyclophosphamide, azathioprine, leflunomide, mycophenolic acid
Prevent cytokine secretion – cyclosporine (inhibits t-lympocytes and their interleukins), corticosteroids
Inhibit cytokine synthesis – NSAIDs, COX-2 inhibitors Block cytokines – anti-TNF Ab
1. Cite indications for the following laboratory studies: ESR, CRP, ANA, c-ANCA, p-ANCA, anti-DNA antibodies, serum complement, Cryoglobulins.
Laboratory Studies IndicationsESR/CRP ANA c-ANCA p-ANCA Anti-DNA Ab Serum Complement Cryoglobulins
↑ d/t inflamm Antinuclear Ab (+) in 40-60% RA pts
Cytoplasmic Antineutrophil Cytoplasmic Ab
Wegener’s granulomatosis
Perinuclear Antineutrophil cytoplasmic Ab
↑ in Polyarteritis nodosa
Serologic marker for SLE High levels reflect acute inflamm
Ig’s that precipate in cold & promote systemic inflamm dz via tissue deposition
2. Differentiate between primary and secondary Raynaud’s phenomenon. Capillary spasms resulting in loss of blood flow that are exacerbated in cold exposure (any part of the body) Effected digits turn white → blue → red
i. Tx: SL or use CCB (but may ↓ BP) 1° : no underlying cause
i. PE is nL between attacks 2° : associated c/ or caused by some other systemic illness of dz process
i. pits/ulcerations on fingertips may be present in pts c/ scleroderma CREST syndrome (Calcinosis, Raynaud’s syndrome, Esophageal dysmotility, Sclerodactyly, Telangiectasias)ii. abnL Allen test indicates fixd arterial occlusion
3. Compare and contrast the epidemiology and pathophysiology of the following categories: autoimmune diseases, vasculitic syndromes, and seronegative spondyloarthropathies. Refer to Table Below4. Describe the characteristic clinical presentation, diagnosis, management, prognosis/characteristic disease course and major complications of the following diseases: Refer to Table Below
∴ therefore, ∵ because, c/ with, s/ without, MCC: Most Common Cause 1
Clinical Medicine III: Block I, MSK Objectives 7: Rheumatology Jimmy Bui
Autoimmune Diseases and Connective Tissue DisordersDisorder Features SSX DX TX/PX
Systemic Lupus Erythematosus
(SLE)
Epi: MC in 20-30s 3x F M≫ AA White≫
1) Malar (butterfly) rash (s/ scarring) triggered by sun exposure d/t photosensitivity
2) Discoid lupus: rash occurs in diff parts of bodies that can result in scarring
3) Subacute cutaneousa. Annularb. Serpinginous
Alopecia (reversible) Arthritis esp small jts of hand Renal : GN, membranous nephritis,, mesangial nephritis Pulm : pleuritic, pneumonitis, interstitial lung dz (pulm fibrosis) Cardiac : pericarditis, myocarditis, coronary vasculitis, CAD, Libman-
Sacks endocarditis (growths on heart valves) Heme : leukopenia, lymphopenia, TP, (+) Coombs hemolytic anemia,
hypercoagulable CNS : peripheral neuropathy, Sz, CVA, organic brain syndrome
(dementia-like), HA, depression, psychosis Ocular : conjunctivitis, episcleritis, Sjögren’s syndrome, CRAO, cytoid
bodies (rare s/ affecting vision)
SLE is dx’d by clinical criteria (Need 4/11)1) Malar rash2) Discoid Rash3) Photosensitivity4) Oral ulcers5) Arthritis6) Serositis7) Renal d/o8) Neuro d/o9) Heme d/o (only 1 pt despite
having several)10) Immunological d/o11) Antinuclear d/o
ANA Test is TERRIBLE for screening SLE
Most valuable if someone has 3 other features of SLE
Skin : hydroxychloroquine (old malaria drug), topical steroids
Jt : NSAIDs, hydroxychloroquine Renal , CNS: corticosteroids,
cyclophosphamide, azathioprine, mycophenolate mofetil, rituximab
Heme : : corticosteroid Serositis : NSAIDs, corticosteroid Steroid sparing : methotrexate,
azathioprine, mycophenolate mofetil, belimumab (newer monoclonal Ab)
Systemic Sclerosis /
Scleroderma
Def Deposition of collagen into skin Often starts off with Raynaud’s
phenomenonEpi 4x F M≫ 40-60yr No hereditary component
Edema of hands Shiny skin Skin pulled tight → fingers pulled into
claw-form Telangioectasia Digital ulcerations @ tips (feels like worst
paper cuts) Interstitial lung dz (aveolar scarring) →
often cause of death Basically CREST syndrome
(+) ANA 90% cases Skin: corticosteroids, peniciliamine, topical NTG
Jt, NSAIDs, corticosteroid Esophagus: PPI Raynaud’s: CCB Renal: ACEi Pulm: corticosteroid,
cyclophosphamide, bosetan Bact overgrowth: broad-spectrum Abx
Sjögren Syndrome
Def: Autoimmune destruction of salivary &
lacrimal glands (exocrine)Epi: F M, middle age≫
Dry eyes (keratoconjunctivitis sicca/xerophthalmia)
Dry mouth (xerostoma) ± salivary gland enlargement May be associated c/ rheumatoid arthritis
or other connective tissue dz Enlarged parotid glands Dry nasal passages, bronchi, cough, skin,
vag
Schirmer’s test: filter paper in eyelid to see tear production
↓ salivary gland flow salivary gland bx → lymphocytes in
glands RF in 70% cases ANA in 60% cases
Dry eyes: Artificial tears, punctal occlusion, cyclosporine
Dry mouth: sugarless lozenges, pilocarpine, cevimeline
Polymyositis Proximal mm weakness (difficulty
getting out of chair & brushing hair)Often painless
Epi 3x F M≫
Proximal mm weakness (difficulty getting out of chair & brushing hair)
Often painless
↑ CPK Myopathic ∆s on EMG Muscle bx → inflamm ∆s
HD Corticosteroid Methotrexate Azathioprine IVIG
Dermatomyositis
Derm manifestations: Heliotrope rash (around eyes) “mechanic’s hands” (hyperkeratosis of
hands) Gottron’s papules over jts
Polymyalgia Rheumatica
(PMR)
Epi 2x F M, ≥ 50yo, White≫ Associated c/ Temporal arteritis
MM pn x ≥ 1mo of shoulders, pelvic girdle Sev morning stiffness & gelling No mm atrophy or true weakness Constitution sx (fever, fatigue, wt loss,
depression)
↑ ESR >40mm/hr or ≥ 100mm/Hr bx for temporal arteritis
LD Corticosteroid x 2yr c/ tapering HD Corticosteroid if (+) temporal
arteritis
∴ therefore, ∵ because, c/ with, s/ without, MCC: Most Common Cause 2
Clinical Medicine III: Block I, MSK Objectives 7: Rheumatology Jimmy Bui
Vascular SyndromesDisorder Features SSX DX TX/PX
Giant Cell Arteritis(Temporal Arteritis)
Inflammation of branches of temporal artery
Local Temporal HA Blindness Scalp necrosis Jaw claudication Neuropathies (CNS,
PNS)
Systemic PMR Fever Anorexia Malaise Wt loss
↑ ESR, abnL LFT, anemia ACR Criteria (need 3/5) Age >50 y/o @ onset New HA Temporal artery: ↓ pulse, TTP Bx → granulomatous inflamm c/
multinucleated giant cells
Corticosteroid Methotrexate Azathioprine
Takayasu’s Arteritis
Def Arteritis of branches of aorta RareEpi F M, 10-40 y/o≫ MC in Japanese
↓ pulses in extremities Cool extremities Claudication
ACR Criteria (need 3/6)1) Age < 40 y/o @ onset2) Claudication3) ↓ brachial artery pulse4) BP diff > 10mmHg b/t arms5) Bruit in subclavian aa or aorta6) Occlusion/narrowing of aortic branches
Corticosteroid Methotrexate Surgical revascularization
Polyarteritis Nodosa
Systemic necrotizing arteritis of medium aaEpi 3x M≫F, 40-60 y/o Associated c/ Hep B (30% cases)
Livedo reticularis Inability to extend hand Mesenteric aa → necrosis of gut, kidneys
Definitive dx: Bx angiogram ↑ESR, CRP, proteinuria (+) Hep B Ag
HD Corticosteroid Cyclophosphamide ACEi
Wegener’s Granulomatosis
(Granulomatosis c/ polyarthritis)
Vasculitis of small & medium vessels
Sinus, pulm, renal involvement
ACR Criteria (need 2/4) Nasal/oral inflame (bloody nasal d/c, oral
ulcer) AbnL CXR (nodules, infiltrates, cavities) Ur sediments (>5 RBC/casts) Bx → granulomatous inflamm
Corticosteroid Cyclophosphamide Limited dz →
methotrexate, azathioprine, TMP/SMZ
Behçet’s Syndrome
Recurrent oral & genital aphthous ulcers
Uveitis→ blindness
Recurrent oral & genital aphthous ulcers Uveitis→ blindness Skin ulcers
Recurrent oral ulcers 2 of following s/ systemic dz:
o recurrent genital ulcero uveitiso skin lesiono (+) pathergy test (papule ≥2mm dev
24-48hr post-oblique insertion of 20-25 gauge needle into skin)
Colchicine Corticosteroid NSAIDs (for jts) Methotraxate Azthioprine Cyclophosphamide
Vasculitis ClassificationArtery Size Clinical Syndrome
Large artery Takayasu’s arteritisLarge & medium artery Giant cell arteritisMedium sized artery Polyarteritis nodosum, Wegener’s granuloma-tosus, CT diseaseSmall vessels Hypersensitivity vasculitis, Henoch-Schönlein purpura, CT disease
∴ therefore, ∵ because, c/ with, s/ without, MCC: Most Common Cause 3
Clinical Medicine III: Block I, MSK Objectives 7: Rheumatology Jimmy Bui
Seronegative SpondyloarthropathiesDisorder Features SSX DX TX/PX
Ankylosing Spondylitis
Onset <40yo Insidious onset Duration >3mo Morning stiffness Improvement c/ exercise
Bilat sacroiliitis Spondylitis Peripheral oligoarthritis Enthesopathy (Achilles tendon) LBP c/ stiffness x >3mo
HLA-B27 Ag present in 95% of whites NSAIDs DMARDs Corticosteroid
Psoriatic Arthritis
Def:Inflamm arthritis c/ skin involvement preceding jt dz by mo-yrsMay resemble RA in clinical presentation but look at labs
Oligoarthritis, Polyarticular DIP involvement Onycholysis Nail pitting “Sausage-finger” appearance
Pathognomonic: Pencil-in-cup hand XR
↑ESR Anemia: normocytic, normochromic RF nL
NSAIDs Methotrexate → arthritis + skin
inflamm DMARDs Reconstructive surg → painful en-stage
antrhopathy
Reactive Arthritis(Reiter’s Syndrome)
Arthritis following GI or GU infection
Asymmetric arthritis MCC nontraumatic monoarthritis Often seqeulae to Ct infn
Tetrad Urethritis Conjunctivitis Oligoarthriris (knee, ankle) Mucosal ulcers (balanitis, stomatitis)
50-80% (+) HLA-B27 (-) synovial fluid cx XR/CT→ permanent/progressive jt dz
1L: PT + NSAIDs Abx @ time to infn to ↓ chance of dev
Reactive Arthritis
Enteropathic Arthritis
Arthritis associated c/ Crohn’s disease or ulcerative colitis
Nonerpsive polyarthritis of large jts Gut inflamm
Stool cx Colonoscopy if GI sx persist (-) HLA-B27
Avoid NSAIDs (may exacerbate GI sx)
Corticosteroids
5. List the historical questions and physical exam findings consistent with fibromyalgia. Refer to Table Below6. Cite the criteria recommended by the American College of Rheumatology for diagnosing fibromyalgia. Refer to Table Below7. Develop a differential diagnosis for fibromyalgia. Refer to Table Below8. Explain the pharmacologic and nonpharmacologic aspects of management for fibromyalgia. Refer to Table Below9. Describe the clinical manifestations of chronic fatigue syndrome. Refer to Table Below10. Explain the pharmacologic and nonpharmacologic aspects of management for chronic fatigue syndrome. Refer to Table Below
Fibromyalgia & Chronic Fatigue SyndromeDisorder Features SSX DX TX/PX
Fibromyalgia(FM)
DDX Pn above & below waist bilat & axial x ≥3mo
Non-articular MSK ache, pn, fatigue, sleep disturbance, multiple tender “trigger” points on PE
Pn an
Dx of exclusion
ACR Criteria1) Pn & sx > 1wk, # of painful areas out of
19 parts of body + fatigue/waking unrefreshed/cognitive sx
2) Sx x ≥ 3mo3) R/O other cause
Non-Rx Aerobic exercise, CBT, Pt edu, strength
training, acupuncture, biofeedback, balneotherapy (warm H2O therapy), hypntherapy
Rx LD TCA (for sleep), SNRI (duloxetine) Analgesics (Tramadol best) AEDs (pregabalin)
SLE Systemic ssx, ANA+
Inflamm myositis Prox mm weakness, little pn, ↑CK
Polymyalgia Rheumatica
Shldr, hip pn, elderly, ↑ESR, resp to steroids
HoT4 AbnL TFTs
Chronic Fatigue Syndrome
(CFS)
Idiopathic chronic fatigue Abrupt onset of fatigue c/ significant impairment of ADL, work ability, social relationships
Often preceded c/ flu-like prodrome Generalized MSK pn, cog dysfxn, IBS,
sleep disturbances
NOT a dx of exclusion (unlike FM)PE: (-) PE findings (unlike FM) Exclude pt c/ fatiguing med d/o,
depression, d/o, substance abuse, sev Ψobesity
Monoarthritis Oligoarthritis Polyarthritis Aches & Pains Gout/pseudogout Infectious arthritis Reactive arthritis OA Trauma
OA Psoriatic arthritis Reactive arthritis Gout/pseudoarthritis RA
RA OA Psoriatic arthritis Pseudogout SLE Gonococcal arthritis
Fibromyalgia Polymyalgia Rheumatica HoT4 Multiple soft tissue problems Hyperextensibility syndrome
∴ therefore, ∵ because, c/ with, s/ without, MCC: Most Common Cause 4